Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantationWei‐Feng Qu, Ying–Hong Shi, Xiaoling Wu et al.|Hepatology International|2023Cited by 58
Deciphering intratumoral heterogeneity of hepatocellular carcinoma with microvascular invasion with radiogenomic analysisYi Wang, Mengsu Zeng, Gui‐Qi Zhu et al.|Journal of Translational Medicine|2023Cited by 36
Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cellsGui‐Qi Zhu, Jia Fan, Zheng Tang et al.|Signal Transduction and Targeted Therapy|2025Cited by 16
Targeting HMGB2 acts as dual immunomodulator by bolstering CD8 <sup>+</sup> T cell function and inhibiting tumor growth in hepatocellular carcinomaWei‐Feng Qu, Ying–Hong Shi, Gui‐Qi Zhu et al.|Science Advances|2025Cited by 11
Deciphering intratumoral heterogeneity of hepatocellular carcinoma with microvascular invasion with radiogenomic analysisYi Wang, Mengsu Zeng, Gui‐Qi Zhu et al.|Research Square|2023Cited by 3